We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...
The lungs that Dr. Ankit Bharat took out of Tadd Crosslin, a 49-year-old father of twins, were marred with billions of cancer cells. They were “perhaps the most diseased that we’ve ever seen,” said ...
Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestProvidence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean ...
Zacks.com on MSN5d
Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards?Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...
and lung cancer DPTX3496 is currently in IND-enabling studies and IND filing is planned for the second half of 2025 BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. – the ...
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. – the leading ... negative breast cancer (TNBC), and non-small cell lung cancer (NSCLC). Based on the preclinical data ...
and lung cancer DPTX3496 is currently in IND-enabling studies and IND filing is planned for the second half of 2025 BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. - the leading ...
and OSLO, Norway, Jan. 28, 2025 /PRNewswire/ -- Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT Therapeutics (Euronext Growth: EXTX), a ...
Oncology is the key focus for Exact Therapeutics, spearheaded by our ongoing Phase 2 trial in locally advanced pancreatic cancer, which received IND clearance at the end of 2024.”, said Dr. Per Walday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback